This could have delayed the onset of cognitive dysfunction symptoms, and the selected three-year interval might be insufficient to detect a statistically significant difference in cognitive decline for both PRS and APOE genotypes other than homozygous ε4/ε4. The gene discussed is APOE; the disease is Mental deterioration.